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Background
Oral candidiasis is a clinical predictor for progression to
AIDS. Antifungal drug resistance is becoming a major
problem with this immunedepleted population. Consid-
ering the above facts, the study was conducted to speci-
ate and to determine the susceptibility pattern of the
Candida isolates from HIV patients with oral candidiasis
and to correlate it with the CD4 count of the patients.
Materials and methods
Samples collected from (n=150) the lesion using sterile
cotton swabs in HIV patients with oral candidiasis. Iso-
lation and speciation were done by standard mycological
procedures. Antifungal susceptibility was determined by
Microbroth dilution method, as per the CLSI guidelines.
Estimation of CD4+ T lymphocyte of the patients was
done by FACS count system.
Results
Of the 150 samples, two revealed a mixture accounting
for the 152 isolates. Candida albicans 118 (78%) was
the most common species followed by Candida tropica-
lis 17 (11%), Candida krusei 8 (5%), Candida parapsilo-
sis 6 (4%), Candida glabrata 2 (1%) and Candida
guilliermondi 1 (1%) . By microbroth dilution 18 (11.8%)
isolates were fluconazole resistant, 23 (15.1%) were itra-
conazole resistant and all were amphotericin susceptible.
Of the 150 patients, 106 (70.6%) had CD4 count <200
cells/ µl. Azole resistant was more common in patients
with CD4 count <200 cells/ µl.
Conclusion
Candida albicans is the most frequently isolated species.
Non- albicans Candida species are emerging as impor-
tant pathogens with increasing rates of azole resistance
and with increased immunosuppression. This empha-
sizes the need for speciation and determination of sus-
ceptibility pattern of the Candida isolates from HIV
patients with oropharyngeal candidiasis.
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